Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy National Research Corporation (NRC) stock
Learn how to easily invest in National Research Corporation stock.
National Research Corporation is a diagnostics & research business based in the US. National Research Corporation shares (NRC) are listed on the NASDAQ and all prices are listed in US Dollars. National Research Corporation employs 485 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in National Research Corporation
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NRC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- NRC shares summary
- Compare share dealing platforms
- Is NRC stock a buy or sell?
- Stock performance over time
- Can I short NRC shares?
- Are NRC shares over-valued?
- National Research Corporation's financials
- How volatile are NRC shares?
- Does National Research Corporation pay a dividend?
- Other common questions
National Research Corporation stock price (NASDAQ: NRC)Use our graph to track the performance of NRC stocks over time.
National Research Corporation shares at a glance
|Latest market close||$47.83|
|52-week range||$42.19 - $59.45|
|50-day moving average||$46.86|
|200-day moving average||$48.15|
|Wall St. target price||N/A|
|Dividend yield||$0.12 (0.23%)|
|Earnings per share (TTM)||$1.35|
Buy National Research Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy National Research Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
National Research Corporation price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||3.48%|
|3 months (2021-04-26)||-2.31%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
Is National Research Corporation under- or over-valued?
Valuing National Research Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of National Research Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
National Research Corporation's P/E ratio
National Research Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 38x. In other words, National Research Corporation shares trade at around 38x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
National Research Corporation's EBITDA
National Research Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $51.2 million.
The EBITDA is a measure of a National Research Corporation's overall financial performance and is widely used to measure a its profitability.
National Research Corporation financials
|Revenue TTM||$134.9 million|
|Operating margin TTM||32.85%|
|Gross profit TTM||$84.1 million|
|Return on assets TTM||21.08%|
|Return on equity TTM||62.85%|
|Market capitalisation||$1.3 billion|
TTM: trailing 12 months
Shorting National Research Corporation shares
There are currently 330,724 National Research Corporation shares held short by investors – that's known as National Research Corporation's "short interest". This figure is 2.1% up from 323,846 last month.
There are a few different ways that this level of interest in shorting National Research Corporation shares can be evaluated.
National Research Corporation's "short interest ratio" (SIR)
National Research Corporation's "short interest ratio" (SIR) is the quantity of National Research Corporation shares currently shorted divided by the average quantity of National Research Corporation shares traded daily (recently around 46190.502793296). National Research Corporation's SIR currently stands at 7.16. In other words for every 100,000 National Research Corporation shares traded daily on the market, roughly 7160 shares are currently held short.
However National Research Corporation's short interest can also be evaluated against the total number of National Research Corporation shares, or, against the total number of tradable National Research Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case National Research Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 National Research Corporation shares in existence, roughly 10 shares are currently held short) or 0.0238% of the tradable shares (for every 100,000 tradable National Research Corporation shares, roughly 24 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against National Research Corporation.
Find out more about how you can short National Research Corporation stock.
National Research Corporation share dividends
Dividend payout ratio: 17.03% of net profits
Recently National Research Corporation has paid out, on average, around 17.03% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.93% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), National Research Corporation shareholders could enjoy a 0.93% return on their shares, in the form of dividend payments. In National Research Corporation's case, that would currently equate to about $0.12 per share.
While National Research Corporation's payout ratio might seem low, this can signify that National Research Corporation is investing more in its future growth.
National Research Corporation's most recent dividend payout was on 14 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2021 (the "ex-dividend date").
National Research Corporation share price volatility
Over the last 12 months, National Research Corporation's shares have ranged in value from as little as $42.1939 up to $59.4454. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while National Research Corporation's is 0.6404. This would suggest that National Research Corporation's shares are less volatile than average (for this exchange).
National Research Corporation overview
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations.
Stocks similar to National Research Corporation
National Research Corporation in the news
National Research Corporation's (NASDAQ:NRC) Stock Is Going Strong: Is the Market Following Fundamentals?
Farmers & Merchants Investments Inc Buys Xilinx Inc, Delta Air Lines Inc, Vanguard Short-Term Bond ETF, Sells VF Corp, Schneider National Inc, AT&T Inc
Touchstone Capital, Inc. Buys National Research Corp, PPG Industries Inc, Sells , Strategic Education Inc
Frequently asked questionsWhat percentage of National Research Corporation is owned by insiders or institutions?
Currently 45.536% of National Research Corporation shares are held by insiders and 44.287% by institutions. How many people work for National Research Corporation?
Latest data suggests 485 work at National Research Corporation. When does the fiscal year end for National Research Corporation?
National Research Corporation's fiscal year ends in December. Where is National Research Corporation based?
National Research Corporation's address is: 1245 Q Street, Lincoln, NE, United States, 68508 What is National Research Corporation's ISIN number?
National Research Corporation's international securities identification number is: US6373722023 What is National Research Corporation's CUSIP number?
National Research Corporation's Committee on Uniform Securities Identification Procedures number is: 637372103
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert